Published in JAMA Network Open · View the paper (DOI)
A study of 385 patients with a history of multisystem inflammatory syndrome in children found no serious COVID-19 vaccine reactions. The vaccine's safety profile appears comparable to that of the general population, at least 90 days after MIS-C diagnosis.
Coverage from 2 institutions